Introducing health economics and the rationale behind key elements of health care systems. Focusing on economic evaluation of health care programmes. Addressing decision rules, structuring decision models, evidence that informs cost-effectiveness models and uncertainty in economic evaluations.
In cooperation with AdriaSonara.
Date: The date has not yet been set.
Day 1 - Health economics
The date has not yet been set, from 9:00 to 16:30
Day 2 - Health economics
The date has not yet been set, from 9:00 to 16:30
Day 3 - Economic Evaluation in Health
The date has not yet been set, from 9:00 to 16:30
Day 4 - Economic Evaluation in Health
The date has not yet been set, from 8:30 to 17:00
Health economics
Economic Evaluation in Health
Employees in healthcare sector, government agencies, pharmaceutical industry, private and public sector workers who are asked to undertake economic assessments, evaluations and bid for funding.
Laura Bojke joined the team for economic evaluation and health technology assessment of the Centre for Health Economics, University of York in 1999. She completed her PhD at York in 2008, titled ‘Characterising structural uncertainty within decision analytic models’. She has worked on a number of projects involving the use of expert elicited data within decision analytic models and is particularly interested in this area and its application to issues of extrapolation uncertainty. Laura has worked on a wide range of applied and methodological projects and has gained extensive experience of modelling the cost-effectiveness of arthritis and musculoskeletal diseases, specially psoriatic arthritis. Laura is currently working on the Collaboration for Leadership in Applied Research and Care (CLAHRC) for Yorkshire and Humber as part of the Health Economics and Outcomes Measurement team. The program of work includes the use of economic evaluation across sectors, economic evaluation for local decision makers and the use of routine data for economic evaluation. Laura contributes to a range of short courses ran at CHE and leads the Assessing the Impact of Medical Technologies on Health module as part of the distance learning MSc in Economic Evaluation for Health Technology Assessment. She is also a member of the Research for Patient Benefit panel for Yorkshire and Humber. Laura is a member of the equality and diversity action group and was a member of the Athena swan group prior to this.
Petra Došenović Bonča is an associate professor at the Faculty of Economics, University of Ljubljana, Slovenia. Her research fields are health economics and public economics. Her current research focuses on efficiency and performance of health care providers in Slovenia and on innovations as factors of efficiency and performance. She is currently a member of the Statistical Advisory Committee for Health at the Statistical Office of the Republic of Slovenia. She is also a member of the Operational Research Society. In the 2013 – 2017 period, she was the coordinator of the international accreditation of business schools EQIUS at the Faculty of Economics. She has published several papers analysing and assessing the Slovenia’s health care system and policy initiatives related to this sector. She has also participated in reform efforts and has been involved in consultancy projects for hospitals in Slovenia. She has participated in the development of the first postgraduate degree programme in Health Economics and anagement offered in Slovenia. Since 2017, she is the head of this programme and currently teaches courses Principles of health economics, Health systems and policies, Economic evaluation in health care and Health insurance.
Vasilisa (Vaska) Sazonov has 15 years of pharmaceutical industry experience in outcomes research, health technology assessment (HTA), reimbursement/market access & commercial innovation in over forty countries worldwide.
Vaska obtained a Masters in Pharmacy degree from the University of Ljubljana (1998), a Masters degree in Health Economics from the University of York, UK (1999), and a PhD degree in Pharmaceutical Economics & Outcomes Research from Purdue University, Indiana, USA (2003). During her studies she completed practical trainings at the US Pharmacopoeia in Rockville, MD, Ciudad Sanitaria de Bellvitge Hospital in Barcelona, Johannesburg General Hospital, Roche Pharmaceuticals in Basel and Merck&Co., Inc in Whitehouse Station, NJ. Vaska’s research areas include HIV, infectious disease, oncology, respiratory diseases, the diseases of the central nervous system, cardiometabolic diseases, women’s health, rheumatology, gastroenterology and osteoporosis. Vaska has lectured at the Forrester Hill Medical Centre, Department of General Practice and Primary Care, Aberdeen and continues to lecture in Pricing & Reimbursement for the International Health Technology Assessment, Pricing and Reimbursement Program at the University of Sheffield as well as University of Ljubljana (School of Economics MBA and School of Pharmacy).
Participation fee: 1.450 € (VAT excluded)
EARLY BIRD: 1.350 € (VAT excluded)
*Seminar has ended. If you would like to be informed about new date, please fill out the form below and we will contact you.
